LMR Partners’s Voyager Therapeutics VYGR Stock Holding History

LMR Partners’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-19,048	Closed	-$147K	–	1135
2023 Q1	$147K	Buy	+19,048	New	+$151K	﹤0.01%	897
2022 Q4	–	Sell	-33,068	Closed	-$196K	–	1286
2022 Q3	$196K	Hold	33,068	–	–	﹤0.01%	1017
2022 Q2	$195K	Buy	33,068 +8,328	+34%	+$56.3K	﹤0.01%	1067
2022 Q1	$189K	Buy	+24,740	New	+$110K	﹤0.01%	1150
2021 Q3	–	Sell	-17,018	Closed	-$70K	–	1207
2021 Q2	$70K	Buy	+17,018	New	+$77.1K	﹤0.01%	933

Other funds holding VYGR

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

LMR Partners's VYGR Position: Q2 2023 in Review

LMR Partners sold out of Voyager Therapeutics (VYGR) in Q2 2023, closing a stake of 19,048 shares — an estimated $147K sold.

LMR Partners first reported a position in VYGR in Q2 2021 and held it in 5 quarters. The position peaked at $196K in Q3 2022. 106 funds tracked by Wall St. Rank hold VYGR as of Q2 2023.

LMR Partners reported no remaining Voyager Therapeutics position as of Q2 2023 after selling out during the quarter.
LMR Partners sold 19,048 Voyager Therapeutics shares in Q2 2023, an estimated $147K.
LMR Partners first reported a position in Voyager Therapeutics in Q2 2021 and held it in 5 quarters.
LMR Partners's Voyager Therapeutics position peaked at $196K in Q3 2022.
106 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2023.

Based on LMR Partners's 13F filing for Q2 2023, filed 14 Aug 2023.